Zimmer Biomet Holdings, Inc. €500,000,000 1.164% Notes due 2027 Underwriting AgreementZimmer Biomet Holdings, Inc. • November 13th, 2019 • Orthopedic, prosthetic & surgical appliances & supplies • New York
Zimmer Biomet Holdings, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, €500,000,000 aggregate principal amount of its 1.164% Notes due 2027 (the “Securities”), to be issued under an indenture (as supplemented prior to the date hereof, the “Base Indenture”) dated as of November 17, 2009, between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”), as supplemented by a sixth supplemental indenture dated as of November 15, 2019 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) between the Company and the Trustee. In connection with the issuance and sale of the Securities, the Company will enter into an Agency Agreement to be dated as of November 15, 2019 (the “Agency Agreement”) between the Company and Elavon Financial Servi
